Li Qianqian, Piao Ying, Zhang Yongguo, Qi Xingshun
Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, China.
Department of Medical Oncology, General Hospital of Northern Theater Command, Shenyang, China.
Front Cardiovasc Med. 2024 Feb 22;11:1342529. doi: 10.3389/fcvm.2024.1342529. eCollection 2024.
Acute extensive portal venous system thrombosis (PVST) can cause lethal complications. Herein, we have for the first time reported the use of anticoagulation combined with systemic thrombolysis by tenecteplase in a male patient with a diagnosis of acute extensive PVST but without liver cirrhosis. After thrombolytic therapy, abdominal pain obviously alleviated. However, urinary bleeding developed, which was reversible by stopping thrombolytic drugs. Finally, this case developed cavernous transformation of the portal vein without portal venous recanalization. In future, the efficacy and safety of tenecteplase should be explored in acute extensive PVST cases.
急性广泛性门静脉系统血栓形成(PVST)可导致致命并发症。在此,我们首次报道了在一名诊断为急性广泛性PVST但无肝硬化的男性患者中使用抗凝联合替奈普酶进行全身溶栓治疗的情况。溶栓治疗后,腹痛明显缓解。然而,出现了血尿,停用溶栓药物后血尿可逆转。最终,该病例发生了门静脉海绵样变,门静脉未再通。未来,应在急性广泛性PVST病例中探索替奈普酶的疗效和安全性。